Diversified Healthcare Trust Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Diversified Healthcare Trust wird ein jährliches Gewinn- und Umsatzwachstum von 32.5% bzw. 7.1% prognostiziert.

Wichtige Informationen

32.5%

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Health Care REITs Gewinnwachstum	31.4%
Wachstumsrate der Einnahmen	7.1%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	21 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Diversified Healthcare Trust provides business updates, amends credit facilities

Feb 01

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:DHC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,727	-127	N/A	N/A	1
12/31/2025	1,637	-248	N/A	N/A	3
12/31/2024	1,512	-312	N/A	N/A	2
6/30/2024	1,460	-352	52	52	N/A
3/31/2024	1,435	-327	33	33	N/A
12/31/2023	1,410	-294	10	10	N/A
9/30/2023	1,386	-256	14	14	N/A
6/30/2023	1,352	-272	23	23	N/A
3/31/2023	1,319	-309	-27	-27	N/A
12/31/2022	1,284	-16	-40	-40	N/A
9/30/2022	1,283	415	-87	-87	N/A
6/30/2022	1,298	407	-122	-122	N/A
3/31/2022	1,331	482	-105	-105	N/A
12/31/2021	1,383	175	-63	-63	N/A
9/30/2021	1,431	-207	-14	-14	N/A
6/30/2021	1,488	-225	75	75	N/A
3/31/2021	1,552	-217	137	137	N/A
12/31/2020	1,632	-139	159	159	N/A
9/30/2020	1,503	-175	229	229	N/A
6/30/2020	1,365	-97	251	251	N/A
3/31/2020	1,216	-109	281	281	N/A
12/31/2019	1,040	-88	266	266	N/A
9/30/2019	1,069	-155	302	302	N/A
6/30/2019	1,092	-80	340	340	N/A
3/31/2019	1,108	81	350	350	N/A
12/31/2018	1,117	287	393	393	N/A
9/30/2018	1,110	470	371	371	N/A
6/30/2018	1,098	459	387	387	N/A
3/31/2018	1,086	351	N/A	389	N/A
12/31/2017	1,075	148	N/A	419	N/A
9/30/2017	1,070	125	N/A	419	N/A
6/30/2017	1,068	119	N/A	422	N/A
3/31/2017	1,064	142	N/A	418	N/A
12/31/2016	1,058	141	N/A	424	N/A
9/30/2016	1,051	108	N/A	427	N/A
6/30/2016	1,043	118	N/A	405	N/A
3/31/2016	1,029	116	N/A	423	N/A
12/31/2015	999	125	N/A	406	N/A
9/30/2015	961	165	N/A	390	N/A
6/30/2015	923	164	N/A	388	N/A
3/31/2015	882	164	N/A	366	N/A
12/31/2014	845	162	N/A	351	N/A
9/30/2014	815	193	N/A	340	N/A
6/30/2014	786	192	N/A	335	N/A
3/31/2014	766	188	N/A	323	N/A
12/31/2013	761	184	N/A	307	N/A
9/30/2013	753	147	N/A	292	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: DHC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: DHC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: DHC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: DHCDie Einnahmen des Unternehmens (7.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: DHCDie Einnahmen des Unternehmens (7.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von DHC in 3 Jahren voraussichtlich hoch sein wird

Diversified Healthcare Trust Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target decreased by 59% to US$0.75

Consensus estimates of losses per share improve by 16%

Price target decreased by 11% to US$1.70

Consensus forecasts updated

Price target decreased to US$3.34

Consensus forecasts updated

Recent updates

Diversified Healthcare Trust: Progress Being Made, But I'm Still Neutral

Diversified Healthcare Trust to Report Q2, 2024 Results on Aug 01, 2024

Diversified Healthcare Trust Approves Election of Dawn K. Neher to the Board

Diversified Healthcare Trust Announces Regular Quarterly Cash Distribution on its Common Shares, Payable on or About May 16, 2024

Diversified Healthcare Trust to Report Q1, 2024 Results on May 06, 2024

Diversified Healthcare Trust, Annual General Meeting, May 31, 2024

Diversified Healthcare Trust: A Look At The 9% Yielding Baby Bonds

Diversified Healthcare Trust to Report Q4, 2023 Results on Feb 26, 2024

Diversified Healthcare Trust: Hurtin' For Certain

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares, Payable on or About February 15, 2024

Diversified Healthcare Trust Announces Chief Executive Officer Changes

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares, Payable on or About November 16, 2023

Diversified Healthcare Trust to Report Q3, 2023 Results on Nov 01, 2023

Diversified Healthcare Trust Appoints Matthew Brown as Chief Financial Officer Effective October 1, 2023

Office Properties Income Trust (NasdaqGS:OPI) cancelled the acquisition of Diversified Healthcare Trust (NasdaqGS:DHC) from Flat Footed LLC and others.

Office Properties Income Trust (NasdaqGS:OPI) cancelled the acquisition of Diversified Healthcare Trust (NasdaqGS:DHC) from Flat Footed LLC and others.

Flat Footed LLC Issues a Letter to the Shareholders of Diversified Healthcare Trust

Flat Footed LLC Releases Presentation with Shareholders of Diversified Healthcare Trust

Flat Footed Issues a Digital Advertisement to Shareholders of Diversified Healthcare Trust

Flat Footed LLC Provides Information to Shareholders of Diversified Healthcare Trust

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares, Payable on or About August 17, 2023

Diversified Healthcare Trust to Report Q2, 2023 Results on Aug 01, 2023

Diversified Healthcare Trust Announces Event of Default Under $450 Million Credit Facility for Insufficient Collateral Value

Flat Footed Provides Information to Shareholders of Diversified Healthcare Trust

Flat Footed LLC Questions the Appropriateness and Timing of Insider Adam D. Portnoy’s Recent Purchases of Diversified Healthcare Stock

Flat Footed Intends to File a Preliminary Proxy Statement with the Securities and Exchange Commission

Flat Footed Sends Letter to the Board of Diversified Healthcare Trust

Diversified Healthcare Trust Declares Quarterly Dividend, Payable on or About May 18, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Diversified Healthcare Trust Reports Impairment of Assets for the Three Months Ended March 31, 2023

Now 24% undervalued

Price target decreased by 59% to US$0.75

Consensus estimates of losses per share improve by 16%

Full year 2022 earnings: EPS exceeds analyst expectations

Price target decreased by 11% to US$1.70

Diversified Healthcare Trust to Report Q4, 2022 Results on Mar 01, 2023

ABP Acquisition LLC entered into an agreement to acquire the remaining 93.7% stake in AlerisLife Inc. (NasdaqCM:ALR) from Diversified Healthcare Trust (NasdaqGS:DHC) and others for $41.2 million.

Diversified Healthcare Trust Receives A Notification Letter from Nasdaq Regarding Minimum Bid Price

Diversified Healthcare Trust Announces Regular Quarterly Cash Distribution, Payable on or About February 16, 2023

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

Diversified Healthcare Trust Announces Quarterly Dividend, Payable on or About November 17, 2022

Diversified Healthcare Trust declares $0.01 dividend

Diversified Healthcare Trust to Report Q3, 2022 Results on Nov 02, 2022

Price target decreased to US$3.34

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Diversified Healthcare Trust (NasdaqGS:DHC) acquired 47071 Bayside Parkway located in Fremont, CA for $82 million.

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares, Payable on or About August 18, 2022

Diversified Healthcare Trust declares $0.01 dividend

Diversified Healthcare Trust to Report Q2, 2022 Results on Aug 03, 2022

An unknown buyer acquired a 10% stake in Two Biotech Medical Office Buildings in Boston's Seaport District from Diversified Healthcare Trust (NasdaqGS:DHC) for approximately $110 million.

Diversified Healthcare sells 10% stake in Boston complex for $108M

Consensus forecasts updated

Diversified Healthcare Trust: A Must Avoid REIT

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to US$3.88

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

Diversified Healthcare Trust to Report Q1, 2022 Results on May 03, 2022

Diversified Healthcare Trust, Annual General Meeting, Jun 02, 2022

Diversified Healthcare Trust, Annual General Meeting, Jun 02, 2022

Diversified Healthcare Trust: Fails To Generate Optimism

Consensus EPS estimates fall by 37%

Price target decreased to US$4.51

Full year 2021 earnings: EPS misses analyst expectations

Price target decreased to US$4.39

Third quarter 2021 earnings released: US$0.38 loss per share (vs US$0.45 loss in 3Q 2020)

Price target increased to US$4.93

Diversified Healthcare Trust: Starting To Become Appealing